Estradiol, des-acylated, and total ghrelin levels might be associated with epithelial ovarian cancer in postmenopausal women
Preprint
Abstract
Background: The present study aimed to investigate the association between estradiol, acylated, des-acylated, total ghrelin levels along with pathological parameters and epithelial ovarian cancer (EOC) odds in postmenopausal women. Methods: A case-control study was carried out on 45 EOC patients and 33 age-matched postmenopausal women as the control group. Plasma levels of estradiol, acylated, des-acylated, and total ghrelin were measured by ELISA method. Results: Estradiol’s plasma levels were significantly higher in EOC patients compared to control women ( P < 0.001). Although acylated, des-acylated, and total ghrelin levels were not associated with EOC in logistic regression models, estradiol levels were significantly related to the increase in EOC odds (OR: 1.083, 95% CI: 1.037-1.13, P < 0.001). However, estradiol levels in the two first quartiles (Q 1 , Q 2 ) were associated with decreased odds of EOC (OR: 0.011, 95% CI: 0.001-0.118, P < 0.001, and OR: 0.030, 95% CI: 0.003-0.284, P = 0.002, respectively). For those patients in the third quartile of plasma des-acylated and total ghrelin compared to those in the highest (Q4), the multivariate odds ratios of EOC were respectively 0.192 and 0.25. Conclusions: In conclusion, higher concentrations of des-acylated and total ghrelin might be associated with the decreased EOC odds. Furthermore, the findings suggest that high levels of estradiol might be a potential odds factor in EOC, however, lower estradiol levels may have a protective effect on EOC development.Keywords
All Related Versions
- Published version: Archives of Medical Research, 52 (3), 324.
This publication has 40 references indexed in Scilit:
- Ghrelin inhibits ovarian epithelial carcinoma cell proliferation in vitroOncology Reports, 2013
- 17β-Oestradiol activates proteolysis and increases invasion through phosphatidylinositol 3-kinase pathway in human cervical cancer cellsEuropean Journal of Obstetrics & Gynecology and Reproductive Biology, 2012
- Estradiol-dependent regulation of angiopoietin expression in breast cancer cellsThe Journal of Steroid Biochemistry and Molecular Biology, 2011
- Endogenous estrogen, testosterone and progesterone levels in relation to breast cancer riskThe Journal of Steroid Biochemistry and Molecular Biology, 2007
- The Convergent Development of Molecular-Targeted Drugs for Cancer Treatment and PreventionClinical Cancer Research, 2007
- Patterns and Progress in Ovarian Cancer Over 14 YearsObstetrics & Gynecology, 2006
- Ghrelin and des-acyl ghrelin inhibit cell death in cardiomyocytes and endothelial cells through ERK1/2 and PI 3-kinase/AKTJournal of Cell Biology, 2002
- Novel Expression and Functional Role of Ghrelin in Rat TestisEndocrinology, 2002
- Transvaginal ultrasonography assessment of ovarian volumes in postmenopausal womenSao Paulo Medical Journal, 1996
- Plasma level of estradiol in patients with ovarian malignant tumorsGynecologic Oncology, 1988